Search results
Results from the WOW.Com Content Network
Chronic obstructive pulmonary disease (COPD) is a type of progressive lung disease characterized by chronic respiratory symptoms and airflow limitation. [8] GOLD 2024 defined COPD as a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea or shortness of breath, cough, sputum production or exacerbations) due to abnormalities of the airways (bronchitis ...
Leobardo Segura Meza, 27, of Pacoima suffers from silicosis, an incurable lung disease that has been afflicting workers who cut and polish engineered stone high in crystalline silica.
Chronic Obstructive Pulmonary Disease is a widespread and progressive lung disease that affects millions of people worldwide. [1] Despite its prevalence, COPD often goes undiagnosed and untreated, leading to significant health complications and reduced quality of life for those affected. [ 2 ]
Many people with chronic obstructive pulmonary disease have a low partial pressure of oxygen in the blood and high partial pressure of carbon dioxide.Treatment with supplemental oxygen may improve their well-being; alternatively, in some this can lead to the adverse effect of elevating the carbon dioxide content in the blood (hypercapnia) to levels that may become toxic.
Although COPD shares similar characteristics with all other obstructive lung diseases, such as the signs of coughing and wheezing, they are distinct conditions in terms of disease onset, frequency of symptoms, and reversibility of airway obstruction. [1] Cystic fibrosis is also sometimes included in obstructive pulmonary disease. [2]
End stage pulmonary disease (ESPD) [2] is the result of chronic progressive lung diseases like COPD, [3] idiopathic pulmonary fibrosis, or systemic progressive diseases that affect the lungs such as cystic fibrosis or granulomatosis with polyangiitis. It is defined as when the lungs can no longer or barely remove enough carbon dioxide or supply ...
The definition of a COPD exacerbation is commonly described as "lost in translation", [9] meaning that there is no universally accepted standard with regard to defining an acute exacerbation of COPD. Many organizations consider it a priority to create such a standard, as it would be a major step forward in the diagnosis and quality of treatment ...
“You got all these people with this disease who need treatment,” he said. “There’s a medication that could really help us tackle this problem, help us dramatically reduce overdose death, and people are having a hard time accessing it.” The anti-medication approach adopted by the U.S. sets it apart from the rest of the developed world.